Previous Article | Next Article 
Mol Cell Biol, June 1998, p. 3620-3632, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Human T-Cell Leukemia Virus Type 1 Tax and Cell
Cycle Progression: Role of Cyclin D-cdk and p110Rb
Christine
Neuveut,1
Kenneth G.
Low,2
Frank
Maldarelli,1
Iris
Schmitt,3
Franca
Majone,4
Ralph
Grassmann,3 and
Kuan-Teh
Jeang1,*
Laboratory of Molecular Microbiology,
National Institute of Allergy and Infectious Diseases, Bethesda,
Maryland 20892-04601;
Institute of Gene
Therapy and Molecular Medicine, Mount Sinai School of Medicine, New
York, New York
10029-65742;
Dipartimento di
Biologia, Universita Degli Studi di Padova, Padova,
Italy4; and
Institut für Klinishe
und Molekulare Virologie, Erlangen, Germany3
Received 16 December 1997/Accepted 24 February 1998
 |
ABSTRACT |
Human T-cell leukemia virus type 1 is etiologically linked to the
development of adult T-cell leukemia and various human neuropathies. The Tax protein of human T-cell leukemia virus type I has been implicated in cellular transformation. Like other oncoproteins, such as
Myc, Jun, and Fos, Tax is a transcriptional activator. How it
mechanistically dysregulates the cell cycle is unclear. Previously, it
was suggested that Tax affects cell-phase transition by forming a
direct protein-protein complex with p16INK4a, thereby
inactivating an inhibitor of G1-to-S-phase progression. Here we show that, in T cells deleted for p16INK4a, Tax can
compel an egress of cells from G0/G1 into S
despite the absence of serum. We also show that in undifferentiated
myocytes, expression of Tax represses cellular differentiation. In both settings, Tax expression was found to increase cyclin D-cdk activity and to enhance pRb phosphorylation. In T cells, a Tax-associated increase in steady-state E2F2 protein was also documented. In searching
for a molecular explanation for these observations, we found that Tax
forms a protein-protein complex with cyclin D3, whereas a point-mutated
and transcriptionally inert Tax mutant failed to form such a complex.
Interestingly, expression of wild-type Tax protein in cells was also
correlated with the induction of a novel hyperphosphorylated cyclin D3
protein. Taken together, these findings suggest that Tax might directly
influence cyclin D-cdk activity and function, perhaps by a route
independent of cdk inhibitors such as p16INK4a.
 |
INTRODUCTION |
Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent for adult T-cell leukemia and various
neurological disorders termed HTLV-1-associated myelopathy (HAM) and
tropical spastic paraparesis (TSP) (reviewed in reference
36). HTLV-1 encodes a 40-kDa
trans-activator protein, Tax, which activates transcription through three 21-bp cyclic AMP responsive elements found in the viral
long terminal repeat (LTR; 6, 10, 22, 39, 78). Tax
has been implicated as the critical viral protein for transformation of
T cells (90). Tax induces tumors and leukemia in transgenic mice in vivo and immortalizes cultured T cells (1, 4, 24, 25, 28,
29, 38, 54, 59, 69, 75).
The exact mechanism through which Tax exerts its oncogenic potential is
not known. It is known, however, that Tax can modulate the expression
of several cellular genes that are involved in cellular proliferation.
For example, Tax upregulates the expression of interleukin-2,
interleukin-2 receptor, c-fos, c-Jun, erg-1, and granulocyte-macrophage
colony-stimulating factor (1, 4, 24, 25, 38, 54, 69, 75).
Tax can also repress the expression of
-polymerase, the p53
promoter, and some functions of c-myc and Bax (7, 40, 71,
85). Additionally, Tax can cooperate with oncoproteins, such as
Ras, in cellular transformation (65) and can induce
morphological changes in cells via its association with intermediate
filaments (83). Tax also associates with other cellular
proteins (42, 60; reviewed in reference
23). How these findings fit together into the
transformation process remains to be investigated further.
Cell cycle dysregulation is a hallmark of transformed cells (reviewed
in references 35, 37, and 64). In
this regard, many viral oncoproteins target components of the cell
cycle, thus impairing orderly phase progression. Normal transition from
one phase of the cell cycle to the next is regulated at
"checkpoints" which are, in part, governed by cyclin-dependent
kinases (CDKs) assembled with partner cyclins. Active CDK-cyclin
complexes are further regulated by phosphorylation-dephosphorylation
events mediated through CDK-activating kinases and phosphatases. CDKs can also be inactivated through physical binding with CDK inhibitory proteins (CKIs) (reviewed in references 27, 37, 55, 58, 63,
72, and 74).
D- and E-type cyclins are important in cell cycle transition from
G1 to S (reviewed in references 27, 72,
and 73). In this regard, the cyclin D-cdk complex is
believed to function by specific phosphorylation of the retinoblastoma
tumor suppressor gene product (pRb) (51, 68).
Hypophosphorylated pRb binds members of the E2F transcription factor
family, leading to inactivation of E2F function and reduced expression
of genes (such as dihydrofolate reductase, DNA polymerase
, and
cyclins) that are critical for S-phase events (reviewed in references
61 and 73). Hyperphosphorylation of pRb disables its E2F-binding, thereby influencing the passage of
cells from G1 into S and cellular proliferation (14,
20). Thus, regulation of pRb phosphorylation by cyclin
D-cdk and CDK inhibitors such as p16INK4a,
p21CIP1, and p27Kip1 is critical in controlling
overall cellular metabolism (reviewed in reference
74).
In considering how viruses evolve mechanisms to overcome pRb-mediated
cell cycle control, three possibilities come to mind. First, viruses
could affect events upstream of pRb by targeting factors such as CDKs
or CKIs. Indeed, recent reports have shown that HTLV-1 Tax might affect
transformation in some cells by a physical binding to
p16INK4a (49, 80). Second, viral oncoproteins
such as adenovirus E1a, human papillomavirus E7, or simian virus 40 large-T antigen can inactivate pRb either through physical binding
(11, 15, 89) or through protein destabilization (5,
44). Third, viruses could act downstream of pRb by directly
increasing the activity of E2F. Hence, ectopic expression of E2F was
sufficient to drive cells from G1 into S (43,
66). In principle, then, viruses can subvert cell cycle
regulation in one or more ways.
In HTLV-1 leukemias, normal cell cycling is dysregulated. One suggested
explanation for this is the binding of Tax protein to
p16INK4a and the consequential inactivation of the
inhibitory effect of p16INK4a on cdk4 (49, 80).
In many cells, however, the gene for p16INK4a is deleted,
and in others the expression of p16INK4a is very low
(80). Therefore, we wondered whether a dominant effect of
Tax on cell cycle progression might occur through alternate paths.
Here, using myoblasts and two different T-cell lines, we describe an
effect of Tax on G1-to-S-phase transition (80). We show that Tax mediates an increase in cyclin D3-dependent cdk4 and
cdk6 activity in cells null for p16INK4a. This increased
kinase function was accompanied by p110Rb hyperphosphorylation and
elevated expression of E2F2. At the same time, we also observed a
physical association between Tax and cyclin D3, which was correlated with increased phosphorylation of the latter. Taken together, these
findings suggest that Tax might activate cyclin D-cdk in a way that is
separate from its ability to complex with p16INK4a. We
propose that Tax has two effects: inactivation of a CDK inhibitor (i.e., p16INK4a) and activation of cyclin D-cdk through a
CKI-independent route(s).
 |
MATERIALS AND METHODS |
Cells and viruses.
JPX9, a derivative of Jurkat cells,
contains an inducible Tax cDNA under the control of the metallothionein
promoter (62). Tax expression can be induced with zinc (120 µM ZnCl2) or cadmium (20 µM CdCl2). JPX9m
cells are counterparts of JPX9 cells that contain a functionally
inactive Tax point mutant (i.e., a single arginine insertion at residue
62 [79a]) that is similarly regulated by either zinc
or cadmium. JPX9, JPX9m, and Jurkat cells were cultured in RPMI 1640 with 10% fetal calf serum (FCS). SS8tet Tax cells are human
CD4+ T cells expressing the tax gene under the
control of a tetracycline-repressible promoter. This cell line was
obtained by transduction of the SS8BTP cell line (87) with a
rhadinovirus vector expressing Tax (69a). Tax is repressed
when these cells are cultured in the presence of 1 µg of tetracycline
per ml (doxycycline). SS8tet Tax cells were propagated in RPMI 1640-GC
medium (Vitromex) with 10% FCS and 20 U of interleukin-2 (IL-2) per
ml. JEG-3 human choriocarcinoma cells and vaccinia viral strains were
from the American Type Culture Collection (Rockville, Md.). JEG-3 cells
were cultured in minimal essential medium (MEM) containing 10% FCS.
HeLa S3 human cervical carcinoma epithelial cells were cultured in
S-MEM containing 5% FCS. vTF7-3 vaccinia strain WR stocks were
amplified in HeLa S3 cells, and titers of the virus were determined on
BSC-1 cells by plaquing (16). For protein expression, cells
were infected at a multiplicity of infection of 10 as previously
described (18). HeLa, C2C12, U2OS, and 293T cells
(from G. P. Nolan, Stanford University, Palo Alto, Calif.)
were cultured in Dulbecco modified Eagle medium (DMEM) containing 10%
FCS. MT4 is a human T-cell line transformed with HTLV-1.
Plasmids.
The Tax expression plasmid HpX contains the Tax
cDNA under the control of the HTLV-1 LTR. DNAs for the expression of
recombinant proteins in mammalian cell lines were generous gifts from
P. Hinds, Harvard Medical School, Boston, Mass. (pCMV-cyclin D1 and
pCMV-cyclin D3), and C. Z. Giam, U.S. Uniformed Health Services,
Bethesda, Md. (pET-11d-TaxH6). pTM3-TaxH6 was constructed by
in-frame insertion into pTM3 of an NcoI-BamHI
fragment containing the full-length Tax coding sequence with
a carboxyl-terminal six-His tag from pET-11d-TaxH6 (17, 56).
pGEX-KG-p16 was a gift from Jack Dixon and pGEX-p19 was a gift from
Charles J. Sherr (St. Jude Children's Research Hospital).
Maltose-binding protein (MBP)-Tax fusion protein was constructed by an
in-frame insertion of the tax cDNA into the pMAL vector
(Invitrogen).
Purification of fusion proteins.
Escherichia coli was
grown overnight in 50 ml of Luria-Bertani (LB) medium with 100 µg of
ampicillin per ml. This overnight culture was inoculated into 500 ml of
LB-ampicillin medium and cultured for an additional 1 h at 37°C.
Fusion proteins were induced by treatment with 0.1 mM IPTG
(isopropyl-
-D-thiogalactopyranoside) for an additional
4 h. Cells were collected by centrifugation at 5,800 × g for 10 min. Bacterial pellets were resuspended into 30 ml
of column buffer (10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol [DTT], and protease inhibitor cocktail [aprotinin,
leupeptin, Pefabloc SC, and EDTA; Boehringer Mannheim]). The cells
were lysed by sonication (Branson) with 10 pulses of 30 s.
Sonicated cells were clarified by centrifuging at 9,000 × g for 30 min at 4°C.
MBP and MBP-Tax fusion proteins were purified with amylose resin
according to the manufacturer's protocol. Resins were washed extensively first with column buffer and then with phosphate-buffered saline (PBS) to remove nonspecifically associated proteins and were
subsequently equilibrated with buffer B (20 mM HEPES [pH 7.9], 20 mM
KCl, 1 mM MgCl2, 17% glycerol, 2 mM DTT).
In vitro binding assays.
Equal amounts of
amylose-immobilized MBP alone or MBP-Tax fusion proteins were incubated
with 5 µl of glutathione S-transferase (GST)-p16 or
GST-p19 for 3 h at 4°C. The resins were washed five times with
buffer B containing 0.1 M KCl. The bound proteins were eluted with
buffer B containing 0.25 M KCl. The eluates were precipitated with
trichloroacetic acid, resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and analyzed by Western blotting.
Transfections.
C2C12 cells were transfected with a Tax
expression plasmid and a neomycin resistance plasmid by using
Lipofectamine reagent (Gibco-BRL); they were then either selected with
G418 to establish stable cell lines or harvested in order to prepare
cellular extracts. JEG-3 and 293T cells were transfected with calcium
phosphate (26).
Flow cytometry.
JPX9 cells were synchronized by serum
starvation for 20 h and then maintained with or without zinc for
16 h. The cells were washed in PBS, resuspended in 0.5 ml of
solution (0.1% sodium citrate, 0.1% Triton, propidium iodide [50
µg/ml]), and incubated at 4°C for 30 min. The DNA content was
analyzed by fluorescence-activated cell sorting (FACS). SS8tet Tax
cells (5 × 105) were cultured in either the presence
(1 µg) or absence of doxycycline and serum starved for 20 h. The
cells were then analyzed as described above.
[3H]thymidine incorporation.
JPX9, JPX9m, and
Jurkat cells were synchronized by serum starvation for 20 h and
treated with or without zinc for 16 h. Cells were then plated into
a 96-well plate and maintained in RPMI containing 1 µCi of
[3H]thymidine per 200 µl for 10 h. Cells were
harvested with a cell harvester, and [3H]thymidine
incorporation was determined by scintillation counting.
Antibodies.
Monoclonal antibody against Tax was from the
AIDS Research and Reference Program Division of AIDS, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health. Polyclonal rabbit antiserum against Tax was prepared in our
laboratory. Antisera against cyclin D1, cyclin D3, cdk4, cdk6, p16,
p19, and E2F2 were from Santa Cruz Biotechnology. Monoclonal antibodies
against pRb and myogenin were from PharMingen. The competitor E2F2
peptide was from Santa Cruz Biotechnology.
Rb kinase assay.
Kinase assays with GST-Rb as
substrate were performed as described previously (12). Cells
(5 × 105) were washed in PBS and resuspended in 500 µl of IP buffer (50 mM HEPES [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1 mM
DTT, 0.1% Tween 20) containing 10% glycerol and protease inhibitor
cocktail (Boehringer Mannheim). Cell lysates were quick frozen on dry
ice. Lysates were thawed and incubated on ice for 2 h and then
microcentrifuged at 14,000 rpm for 10 min. Lysates were precleared by
incubation with protein A-protein G-agarose for 2 h at 4°C and
then centrifuged, followed by equilibration with specific antiserum at
4°C overnight. After incubation with antibody, protein A-G-protein
agarose was added at 4°C for an additional 2 h. Immune
complexes on beads were then washed three times with IP buffer
and twice with Rb kinase buffer (50 mM HEPES [pH 8.0], 10 mM
MgCl2, 1 mM DTT). The beads were resuspended into 30 µl
of Rb kinase buffer containing 2 µg of GST-Rb (Santa Cruz
Biotechnology), 2.5 mM EGTA, 10 mM
-glycerophosphate, 0.1 mM sodium
orthovanadate, 1 mM NaF, 20 µM ATP, and 5 µCi of
[
-32P]ATP and then incubated at 30°C for 30 min. The
reaction was stopped by the addition of SDS sample buffer. The samples
were boiled for 5 min, resolved by SDS-10% PAGE, and visualized and quantified with a phosphorimager (Fuji).
Protein analysis.
For Western blot analysis, 2 × 106 cells were washed with PBS and resuspended in
radioimmunoprecipitation assay buffer (150 mM NaCl, 1% Nonidet P-40,
0.5% desoxycholate, 0.1% SDS, 50 mM Tris-HCl [pH 8.0]). Identical
amounts of proteins were resolved by SDS-PAGE and transferred to
Immobilon-P (Millipore) membrane, which was blocked with buffer (0.2%
I-block [Tropix] in 1× PBS and 0.1% Tween 20). Membranes were
incubated overnight with primary antisera. Reactive proteins were
developed with secondary antibodies conjugated to alkaline phosphatase
and visualized by using chemiluminescence according to the
manufacturer's protocol (Tropix).
For immunoprecipitation, cells were lysed in buffer (0.15 M NaCl, 50 mM
Tris-HCl [pH 7.4], 0.5% [vol/vol] Nonidet P-40) containing 0.1 mM
phenylmethylsulfonyl fluoride, and 2.5 µg each of aprotinin, leupeptin, and pepstatin A per ml for 30 min at 4°C. Cellular debris
was pelleted at 14,000 × g for 10 min and discarded.
Clarified extracts were incubated with either polyclonal anti-Tax,
anti-cyclin D3, or anti-cyclin D1 for 16 h and then with 50 µl
of 50% (vol/vol) protein A-protein G-Sepharose for an additional
4 h. The bound complexes were washed three times with 1 ml of
lysis buffer, and the proteins were resolved by SDS-PAGE.
PCR analysis.
Cells (5 × 105) were
resuspended in 100 µl of lysis buffer (50 mM KCl, 15 mM Tris-HCl [pH
8.0], 2.5 mM MgCl2, 0.5% Tween 20, 120 µg proteinase K
per ml), incubated at 56°C for 1 h, and then boiled for 10 min.
Then 5-µl portions of the extract were used in 100 µl of PCR
mixture. Analysis of p15INK4b genomic DNA was done with two
different set of primers: one set for the first exon,
5'-CGCGAGGAGAACAAGGGCAT-3' and
5'-ATCGCGCGCCTCCCGAAAC-3', and one set for the second exon,
5'-TGGGCAGCGCCCGCGTG-3' and 5'-AGTCCCCCGTGGCTGTGC-3'. Primers for the actin gene were used as a control: sense,
5'-ATCAAGATCCTGACCGAGCG-3', and antisense,
5'-TACTTGCGCTCAGGAGGAGC-3'.
 |
RESULTS |
Tax induces progression from G0/G1 to
S.
The effect of Tax expression on cell cycle progression was
studied by FACS. We analyzed Jurkat and JPX9 (a cell line derived from
Jurkat that has been engineered to express Tax upon treatment with
either cadmium or zinc [62]) (Fig.
1A). JPX9 and Jurkat cultures were
synchronized by cultivation in serum-free medium for 20 h, after
which virtually 100% of cells were found in
G0/G1 (Fig.
2A, top
panels). Under this serum-free condition, when JPX-9 cells were treated
with cadmium, Tax expression was induced (Fig. 1A). Induction of Tax
was correlated with 30% of cells (S and G2/M, 25.11 and
5.55%, respectively) egressing from G0/G1
(Fig. 2A, bottom left panel). By contrast, parallel treatment of Jurkat cells produced a much-reduced progression of cells (19% of cells exited from G0/G1) (Fig. 2A, middle left
panel). Although treatment with divalent cation (Cd2+) has
some general effects on cellular metabolism, induction of Tax synthesis
accounts for the additional 11% of cells that exited G0/G1. When the cells were treated with serum
plus cadmium (Fig. 2A, middle right and bottom right panels), similar
fractions of Jurkat (35%) (Fig. 2A, middle right panel) or JPX9 (39%)
(Fig. 2A, bottom right panel) cells exited from
G0/G1 into later phases. These results are
consistent with Tax providing a cell cycle growth function which is
redundant with that of serum. In the absence of serum, Tax expression
is seen to be sufficient to drive a significant number of cells from
G0/G1 into S.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Inducible expression of Tax in JPX9 and SS8tet Tax T
cells. Expression of Tax was assessed by Western blotting with a
monoclonal antibody. (A) Tax was induced in JPX9 with zinc (+). ,
Mock-treated cells. (B) Expression of Tax was repressed in SS8tet Tax
cells with 1 µg of doxycycline (Dox) added to the culture medium (+).
, Mock-treated cells.
|
|

View larger version (18K):
[in this window]
[in a new window]

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
Tax induces the progression of cells from
G0/G1 into S phase. The effect of Tax on the
cell cycle was examined in either JPX9 or SS8tet Tax cells by FACS. (A)
The DNA contents of synchronized cadmium-treated JPX9 cells expressing
Tax in the presence (+serum+Cd) or absence (+Cd) of serum were analyzed
by propidium iodide staining and compared to the identically treated
parental Jurkat cell line with (+serum+Cd) or without (+Cd) serum. The
DNA contents of JPX9 and Jurkat cells without cadmium and without serum
are shown. Open line reflects actual values. Filled areas are the
values interpreted from the MODFIT program. The short peaks to
the left in the bottom panels are indicative of apoptotic cells. (B)
The DNA contents of SS8tet Tax cells expressing ( Dox) or not
expressing (+Dox) Tax were analyzed by propidium iodide staining. The
cells were serum starved for 20 h and then stained with propidium
iodide and analyzed by flow cytometry. In these profiles, the gating
was such that apoptotic cells were not graphed. However, a
significantly higher number of apoptotic cells was seen with cells
expressing Tax. (C) Control DNA profiles of the parental cell
line for SS8tet Tax (SS8 BPT) were examined after serum starvation for
20 h and treatment with (+Dox) or without ( Dox) doxycycline.
|
|
To verify that Tax has a general (as opposed to cell-specific) effect
on cell cycling, we repeated this study in a second Tax-inducible cell
line. Here, the cell cycling profile of a second human CD4+
T-lymphocyte (SS8tet Tax) line that has tax under the
control of a tetracycline-regulated promoter was analyzed. In this
system, Tax expression is repressed when SS8tet Tax cells are
propagated in the presence of tetracycline, and removal of tetracycline
induces Tax synthesis (Fig. 1B). We cultured SS8tet Tax with or without doxycycline (a tetracycline analog) in serum-free medium for 20 h.
The relative DNA contents of cells after propidium iodide staining were
quantified by FACS (Fig. 2B). We found that in cells with the SS8
background, Tax expression increased by more than twofold the relative
fraction of cells that progressed from G0/G1
into S (16.03% of the cells in S phase for Tax-expressing cells versus 7.51% of the cells in S phase for non-Tax-expressing cells) (Fig. 2B).
Figure 2C shows control doxycycline treatment of the parental SS8PBT
cells from which the SS8tet Tax cells were derived. These analyses show
that doxycycline treatment alone has little effect on cell cycle
progression (Fig. 2C, compare right and left panels).
Tax increases cyclin D-cdk4 and cyclin D-cdk6 activities.
The
above results suggest that Tax can accelerate phase progression from
G0/G1 into S. This transition is, in part,
controlled by the activity of G1 cyclin-cdk's which
include D cyclins associated with either cdk4 or cdk6 and E cyclins
associated with cdk2 (reviewed in references 27, 37,
and 64). Previously, it was shown that Tax
physically complexes with p16INK4a, resulting in abrogation
of the inhibitory effects of this CKI (49, 80). However,
most human T cells have very low ambient levels of
p16INK4a, leading us to wonder whether, in addition to the
removal of this negative effect, Tax might not also exert a positive
effect in increasing directly G1 cyclin-cdk function. To
address this hypothesis, we analyzed cells (Jurkat and JPX9) (Fig. 3)
which are null for p16INK4a (80) for a Tax
effect on cdk4 and cdk6.
We conducted in vitro assays with pRb, a physiological substrate for
cdk4 and cdk6, as the phosphate accepter. Extracts were prepared from
synchronized Jurkat and JPX9 cells treated for 8 h with or without
zinc. JPX9 cells cultured with zinc synthesize Tax (see Fig. 1A) and,
when correlated with Tax induction, we observed that cdk4-associated
and cyclin D3-associated kinase activities increased by 6.5- and
3.5-fold, respectively (Fig. 3A, lanes 6 and 13). In comparison, Jurkat cells treated in parallel either with or
without zinc showed no increase in kinase activity (Fig. 3A, lanes 3 and 10). A similar observation was made for cdk6. The cdk6-specific
pRb-phosphorylating activity increased by 8.5-fold when Tax expression
was induced with zinc (Fig. 3A, lane 17) but not in the control cells
(Fig. 3, lane 15).

View larger version (18K):
[in this window]
[in a new window]

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Activation of cyclin D-cdk4 and cyclin D-cdk6 kinases by
Tax. (A) Jurkat or JPX9 cells were synchronized by serum starvation for
20 h. Cells propagated in the presence (+; lanes 3, 6, 10, 13, 15, and 17) or absence ( ; lanes 1, 2, 4, 5, 8, 9, 11, 12, 14, and 16) of
zinc were harvested at the indicated time (in hours). Cell extracts
were immunoprecipitated with anti-cdk4 (lanes 1 to 6), anti-cyclin D3
(lanes 8 to 13), and anti-cdk6 (lanes 14 to 17), or a control
irrelevant (lanes 7 and 18) antibody. The immunoprecipitates were
tested for kinase activity with GST-Rb as substrate. In the top left
panel, the cdk4 activities are shown; in the bottom left panel,
the cyclin D3-associated kinase activities are shown. In the
right panel (lanes 14 to 17) extracts were harvested after 8 h of
induction with zinc, and the cdk6 kinase activities were assayed. (B)
In vitro kinase assays with GST-Rb as substrate with anti-cdk4
immunoprecipitates from exponentially growing SS8tet Tax cells
expressing ( Dox; lane 2) or not expressing (+Dox; lane 1) Tax.
Quantitations of each series of activities are shown in bar graphs.
|
|
To verify these findings in a different cellular background, we
analyzed SS8tet Tax cells. Extracts prepared from cells propagated either with or without doxycycline were immunoprecipitated, and kinase
assays were performed with GST-Rb as the substrate. In the absence of
doxycycline (Tax synthesis is induced), we observed a fourfold increase
in cdk4 activity (Fig. 3B, lane 2) compared to control cells propagated
in the presence of doxycycline (Fig. 3B, lane 1). In SS8tet Tax cells,
no significant change in cdk6 activity was correlated with Tax
induction (59a). Thus, the relative contributions of cdk4
and cdk6 appear to vary in different cells. Taken together, these
results suggest that even in p16INK4a-deleted cells, Tax
can modulate cell cycling through cdk4 and/or cdk6.
Tax expression correlates with pRb hyperphosphorylation.
D-type cyclin-cdks phosphorylate pRb (14, 20, 45). pRb
is hypophosphorylated in G1 and becomes increasingly
phosphorylated just before S (reviewed in reference
33). Hypophosphorylated pRb binds and negatively
regulates members of the E2F transcription factor family.
Phosphorylation of pRb dissociates it from E2F, resulting in the
release of the latter, which in turn activates transcription of
S-phase-specific genes. Because pRb is one downstream substrate for
cyclin D-cdk4 and cyclin D-cdk6, we investigated whether the activation
of these kinases by Tax expression results in enhanced pRb
phosphorylation.
Tax was induced by treatment with zinc of synchronized JPX9 cells.
Total cellular extract was analyzed by SDS-PAGE followed by
immunoblotting with anti-Rb (Fig. 4A). In
the absence of induction a single hypophosphorylated pRb band was
observed in JPX9 cells (Fig. 4A, lane 1). In contrast, when Tax was
induced with zinc nearly 50% of the Rb species became
hyperphosphorylated (ppRb; Fig. 4A, lane 2). This observation is
consistent with a Tax effect on cdk4 and cdk6 resulting in downstream
phosphorylation of pRb.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Tax induces hyperphosphorylation of Rb. (A) The status
of Rb phosphorylation was determined by Western blotting with anti-Rb
in JPX9 cells synchronized first by serum starvation and then cultured
with (+; lane 2) or without ( ; lane 1) zinc. Cells were harvested
8 h after addition of zinc. pRb, Hypophosphorylated Rb; ppRb,
hyperphosphorylated Rb. (B) Rb was detected by Western blotting in
SS8tet Tax cells expressing Tax (+) and in SS8tet Tax cells not
expressing Tax ( ) (lanes 1 and 2) with anti-Rb. ppRb is the
hyperphosphorylated form of Rb; pRb is the hypophosphorylated form. (C)
Increased expression of E2F2 upon Tax induction. E2F2 was examined in
extracts from SS8tet Tax cultured in the absence (+; lanes 2 and 4) or
presence ( ; lanes 1 and 3) of doxycycline by Western blotting by
using an E2F2-specific antibody (left panel) or E2F2-specific antibody
competed by mixing with a 2-µg/ml solution of the immunizing E2F2
peptide (right panel). The immunizing peptide competed specifically
with a protein of an apparent size of 53 kDa but not with nonspecific
lower-molecular-mass bands.
|
|
Effects of Tax on Rb phosphorylation were also verified in SS8tet Tax
cells. In SS8tet Tax, when Tax was not expressed, both pRb and ppRb
were found (Fig. 4B, lane 2). However, upon Tax induction, the ratio of
hyperphosphorylated versus hypophosphorylated Rb changed from 0.3:1
(Fig. 4B, lane 2) to 1.2:1 (Fig. 4B, lane 1), a finding consistent with
a fourfold increase in the former species. Thus, while ppRb is
basally more abundant in SS8tet Tax (Fig. 4B) than in JPX9 (Fig. 4A),
Tax synthesis in both cells results consistently in increased
phosphorylation of pRb.
pRb hyperphosphorylation correlates with increased E2F activities. This
has been characterized best for the E2F1 protein (reviewed in reference
77). Tax induction in JPX9 and SS8tet Tax cells was
found to result in the upregulation of several E2F-responsive genes
(59a). This is consistent with Tax-associated changes in cyclin D-cdk4 and cyclin D-cdk6 and with phosphorylated pRb as described above (Fig. 3 and 4). To define better which member of the
E2F family might be correlated with Tax expression, we immunoblotted
SS8tet Tax cells to determine the amounts of E2F1 and E2F2. While Tax
expression did not alter the ambient amounts of E2F1 (data not shown),
it resulted in more than a threefold increase in the amount of E2F2
(Fig. 4C, compare lanes 1 and 2). Peptide competition experiments
confirmed that the induced protein is indeed E2F2 (Fig. 4C, lanes 3 and
4).
Tax affects differentiation of myocytes into myotubes.
The
activities of D cyclins and Rb play important roles in cellular
differentiation. For example, ectopic expression of cyclins D2 and D3
in 32D myeloid cells inhibits differentiation (46). Overexpression of cyclin D1 also prevents MyoD-activated expression of
muscle-specific genes (67, 76). Similarly, Rb provides an
essential function in maintaining the postmitotic state of differentiated myotubes (30, 70). Thus, myogenic
differentiation is linked to increased amounts of Rb mRNA and the
hypophosphorylated form of Rb protein (30, 50, 86).
Accordingly, the myocyte-myotube system affords another measure of the
generality of Tax, cyclin D-cdk, and Rb interaction in a cellular
background distinct from that of T cells.
We selected for C2C12 myocytes that express Tax stably. Three
Tax-expressing cell lines were independently isolated and in follow-up
analyses showed similar results. For illustrative purposes, two cell
lines (C2C12 cl3 and C2C12 cl6) are shown in Fig.
5A. Of the two lines, the C2C12 cl6
expresses more Tax protein. C2C12 cl6 (Fig. 5A, lane 3) was compared to
a C2C12 line that was selected only for G418 resistance (Fig. 5A, lane
1). Both cell lines were cultured until 95% confluence; Rb status and
cdk4- and cyclin D1-associated activities were then assayed. When we
compared C2C12 cl6 to C2C12, we found that the latter expressed pRb and
ppRb at a 1:1 ratio, whereas the former expressed the two forms at a
1:10 ratio (Fig. 5B, compare lanes 1 and 2). In vitro kinase assays of
cdk4 (Fig. 5B, lanes 3 and 4)- or cyclin D1 (Fig. 5B, lanes 5 and
6)-associated activities showed relative increases of 3- and 10-fold in
C2C12 cl6 compared to C2C12. Thus, consistent with the results found
for T cells, Tax expression in muscle cells is also correlated with
increased cyclin D-cdk activity and pRb hyperphosphorylation.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
Tax induces cyclin D1-cdk4 kinase activity in C2C12
myoblasts and inhibits the differentiation of myoblasts into myotubes.
(A) C2C12 cells stably expressing Tax were engineered by cotransfection
of a vector encoding Tax under the control of the HTLV-1 LTR and a
vector expressing neomycin resistance. The control cells were
transfected with neomycin resistance vector alone. Stable expression of
Tax (lanes 2 and 3) in two illustrative cell lines (C2C12 cl3 and C2C12
cl6) is shown by Western blotting with Tax-specific serum. (B) C2C12
cl6 and the C2C12 vector-selected control were cultured to 95%
confluence, harvested, and probed for Rb expression (lanes 1 and 2) by
Western blotting. Compared to C2C12, the hyperphosphorylated form
predominates in C2C12 cl6 (upper panel). The lower panels show
Rb-kinase assays performed with immunoprecipitates of normalized cell
extracts with anti-cdk4 (lanes 3 and 4) or anti-cyclin D1 (lanes 5 and
6) antibody. (C) C2C12 vector-selected (top; non-Tax-expressing) and
C2C12 cl6 (bottom; Tax-expressing) cells were grown in DMEM 2% horse
serum (differentiating medium). After 6 days cells were fixed in
staining solution. Long dark tubular morphology indicates
differentiation of cells into myotubes. (D) Expression of Tax in C2C12
myoblasts decreases the differentiation specific marker, myogenin.
C2C12 cells were transiently lipofected either with 2 µg of Tax
expression vector (+) or with 2 µg of a control vector ( ). At
15 h after lipofection, cells were cultured in differentiating
medium (DMEM-2% horse serum) for an additional 48 h. Cell
extracts were normalized and prepared as described in Materials and
Methods, resolved by SDS-PAGE, and analyzed by immunoblotting with a
monoclonal Tax antibody (upper panel) or a monoclonal myogenin antibody
(lower panel).
|
|
Next, we asked whether the biochemical consequences of Tax expression
in muscle cells correlate with morphological differentiation. Are the
effects of Tax on cyclin D-cdk and pRb reflected in the ability of
myocytes to become myotubes? To address this question, we propagated
C2C12 cl6 and C2C12 control lines in differentiation-inducing medium
and then compared the morphological features. When the cells were
stained, it was evident that C2C12 abundantly differentiated into
myotubes, whereas C2C12 cl6 showed only rare changes (Fig. 5C).
Muscle cell differentiation can also be defined with biochemical
markers. To this end, we asked whether Tax expression correlates with
changes in muscle-specific proteins. To avoid biases that might emerge
from clonal selection, we introduced transiently into C2C12 cells
either a Tax or a control vector; immunoblotting verified that cells
that received Tax DNA, but not cells that received vector DNA,
expressed Tax protein (Fig. 5D, compare lanes 2 and 1). At 16 h
after transfection, cells were shifted into differentiation-inducing
medium for an additional 48 h. Cells were then assessed by Western
blotting for myogenin, a basic helix-loop-helix protein which is
synthesized early in myotube morphogenesis. In agreement with the
morphological changes presented in Fig. 5C, the immunoblot
results in Fig. 5D show that Tax-expressing myocytes (Fig. 5C,
lane 4) had fivefold less myogenin than control cells (Fig.
5C, lane 3).
Tax but not a Tax point-mutant binds cyclin D3.
The T-cell and
myocyte results point to a common effect of Tax on cyclin D-cdk's. To
understand better how Tax might influence cyclin D-cdk's, we checked
JPX9 cells to see whether the ambient expression of these proteins is
affected by Tax. Synchronized JPX9 cells treated with or without zinc
were analyzed by Western blotting with anti-cyclin D3, anti-cdk4,
anti-cdk6, or anti-actin antibody. Fig.
6A shows that none of the expression
profiles for cyclin D3, cdk4, or cdk6 changed significantly in JPX9
cells, whether treated or not with zinc. Unexpectedly, we noted that in
Tax-expressing cells, anti-cyclin D3 antibody revealed two closely
migrating bands, with the slower-migrating band being predominant. This
mobility change in cyclin D3 suggested a modification in
phosphorylation. Indeed, when the lower-mobility cyclin D3 band was
treated with calf intestinal phosphatase (CIP), it was converted to the
faster-migrating moiety (Fig. 6B). While this finding is
intriguing, how Tax affects this phosphorylation event and how
this alteration might influence G1 cyclin-cdk activity remain to be investigated further.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of Tax on cyclin D-cdk4 and cyclin D-cdk6. (A)
JPX9 cells were synchronized by serum starvation and then cultured with
(+; lane 2) or without ( ; lane 1) zinc for 8 h. Cell extracts
were prepared and assayed by Western blotting for the expression of
cyclin D3, cdk4, cdk6, or actin. Note that upon zinc induction, cyclin
D3 appears as a doublet with a mass predominance in the
slower-migrating form. (B) Sensitivity of the slower migrating form of
cyclin D3 in JPX9 cells to phosphatase. Cell extracts from JPX9 cells
were treated for 8 h with zinc (lanes 1 and 2); one extract was
further incubated for 1 h at 0°C with 40 U of CIP (lane 2).
Extracts were analyzed by Western blotting with anti-cyclin D3
antibody. The sample in lane 2 showed a distinct change in relative
migration upon CIP treatment.
|
|
The phosphorylation of cyclin D3 prompted us to explore whether Tax
might directly contact this protein. To address this possibility, we
coexpressed cyclin D3 and/or cyclin D1 with Tax in JEG-3
choriocarcinoma cells with the vaccinia virus-T7 RNA polymerase.
The cells were subsequently labeled with [35S]methionine
(Fig. 7A, left and right panels), and
protein complexes were immunoprecipitated with anti-cyclin D3,
anti-cyclin D1, or anti-Tax antibody. In reciprocal assays, we found
that coexpression of Tax with either cyclin D3 or cyclin D1 resulted in
the recovery of protein-protein complexes (Fig. 7A). Thus,
cyclins D1 and D3 were found in anti-Tax immunoprecipitates, and
Tax was present in immunoprecipitates that contain either cyclin D1 or
cyclin D3.

View larger version (15K):
[in this window]
[in a new window]

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
Tax coimmunoprecipitates with cyclin D1 and/or cyclin
D3. (A) Intracellular complex of Tax with cyclin D3 or D1. In the left
panel, each lane represents JEG-3 cells transiently transfected with 5 µg of pTM3-TaxH6 (lanes 3, 4, 7, and 8) and/or 5 µg of pCMV-cyclin
D3 (cyc D3; lanes 2, 4, 6, and 8), infected with 2 × 106 PFU of vTF7-3 vaccinia strain WR for 18 h, and
subsequently labeled with [35S]methionine. Protein
complexes were identified by immunoprecipitation under native
conditions with polyclonal antisera raised against either cyclin D3
( cyclin D3) or Tax ( Tax). Results are representative of two
different experiments. In the right panel, JEG-3 cells were transiently
transfected with 5 µg of pTM3-TaxH6 (lanes 2, 4, 6, and 8) and/or 5 µg of pCMV-cyclin D1 (cyc D1) (lanes 3, 4, 7, and 8), infected with
2 × 106 PFU of vTF7-3 vaccinia strain WR for 18 h and subsequently labeled with [35S]methionine. Protein
complexes were identified by immunoprecipitation under native
conditions with a polyclonal antisera raised against either cyclin D1
( D1) or Tax ( Tax). Results are representative of three different
experiments. (B) In the top panel, detection of Tax
coimmunoprecipitated with cyclin D1 or cyclin D3 by Western blotting is
shown. Each lane represents 5 × 106 293T cells
transiently transfected for 48 h with 20 µg of pCMV-Tax (lanes 1 to 6) and 20 µg of either pCMV-cyclin D1 (lanes 1 to 4) or
pCMV-cyclin D3 (lanes 5 and 6). Protein complexes were
immunoprecipitated under native conditions with polyclonal antisera
raised against either Tax ( Tax; lanes 1 and 2), cyclin D1 ( cyc
D1; lanes 3 and 4) or cyclin D3 ( cyc D3; lanes 5 and 6), and the
presence of Tax was detected by Western blotting with polyclonal
antisera against Tax ( Tax). Results are representative of two
different experiments. In the middle and bottom panels, each lane
represents 5 × 106 293T cells transiently transfected
with 20 µg of pCMV-Tax (lanes 1 to 4) and 20 µg of either
pCMV-cyclin D1 (middle panel) or pCMV-cyclin D3 (bottom panel) for
48 h. Protein complexes were immunoprecipitated under native
conditions with polyclonal antisera raised against either cyclin D1
( cyc D1; middle panel, lanes 1 and 2), Tax ( Tax; middle panel,
lanes 3 and 4; bottom panel, lanes 3 and 4), or cyclin D3 ( cyc D3;
bottom panel, lanes 1 and 2). The presence of either cyclin D1 (middle
panel) or cyclin D3 (bottom panel) was detected by Western blotting
with polyclonal antisera raised against cyclin D1 (middle panel) or
against cyclin D3 (bottom panel). Results are representative of two
different experiments.
|
|
To confirm that the proteins coimmunoprecipitating with Tax are cyclin
D3 and cyclin D1, the experiments were repeated in 293T cells.
Transiently transfected cells were lysed; proteins were
immunoprecipitated, and the identities of coimmunoprecipitated proteins were verified by Western blotting. Antiserum to Tax was used
to demonstrate that both cyclin D1 and cyclin D3 coimmunoprecipitated with Tax (Fig. 7B, lanes 3 to 6). More Tax protein was recovered with
anti-cyclin D3 than with anti-cyclin D1 antibody. We do not have a
clear explanation for this difference, which was confirmed in
reciprocal immunoprecipitations with anti-Tax antibody (see Fig. 7B,
middle and bottom panels). Thus, the results obtained with JEG-3 and
293T cells are in good agreement.
The generality and specificity of Tax and cyclin D3 interactions were
examined further in T cells. We asked whether Tax and an inactive
point-mutated Tax protein would associate differently with cyclin D3.
We also sought to determine whether active and inactive Tax proteins
would affect cell cycle progression from G1 to S
differently. To address these issues, we compared JPX9 with JPX9m
cells. JPX9m is identical to JPX9 except that it expresses a Tax mutant
protein that is inactivated by the insertion of a single arginine at
position 62 (79a). Extracts from induced JPX9 and JPX9m
cells were immunoprecipitated with anti-cyclin D3 antibody. The results
showed that wild-type Tax but not point-mutated Tax coimmunoprecipitated with cyclin D3 (Fig.
8B, lane 4). Thus, a single insertion at
position 62 of Tax prevents its interaction with cyclin D3. We next
asked how the loss of association between Tax mutant and cyclin D3
might be reflected in cell cycle progression and in kinase activities.
JPX9 and JPX9m cells were therefore serum starved to halt cells in
G1 phase. Cells were then treated or not treated with zinc,
and cell cycle progression into S phase was monitored by measuring the
incorporation of [3H]thymidine. As shown in Fig. 8C,
induction of functional Tax protein by zinc in JPX9 cells efficiently
resulted in the incorporation of [3H]thymidine. In
contrast, induction of nonfunctional Tax in JPX9m cells resulted in
66% less incorporation of [3H]thymidine (Fig. 8C, right
panel). This finding supports a role for functional Tax protein in
compelling cell cycle progression from G1 to S. To assess
further the effect of Tax on cyclin D-kinase activities, extracts were
prepared from JPX9 and JPX9m cells with or without zinc induction;
cyclin D-kinase activities were assayed after immunoprecipitation.
Increased cdk6- and cyclin D3-associated kinase activities (Fig. 8D,
lanes 5 and 6 and lanes 9 and 10) were seen in JPX9 samples upon Tax
induction. In contrast, JPX9m samples (with or without zinc) exhibited
no difference in kinase activities (Fig. 8D, lanes 7 and 8 and lanes 11 and 12). Anti-cdk4 results (59a) were similar to the
anti-cdk6 profiles.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 8.
A Tax point mutant neither coimmunoprecipitates with
cyclin D3 nor induces increased cyclin D3-cdk6 kinase activity. (A)
Inducible expression of Tax in JPX9 and JPX9m cell lines. Expression of
Tax wild-type and Tax mutant was assessed by Western blotting with a
monoclonal antibody to Tax. +, Tax wild type and mutant induced in JPX9
and JPX9m strains with zinc; , control mock-treated cells. JPX9m
expresses a transcriptionally inactive Tax mutant that contains a
single amino acid (arginine) inserted at position 62. (B) JPX9 or JPX9m
cells were treated (lanes 2 and 4) or mock treated with zinc (lanes 1 and 3) for 16 h. After solubilization in lysis buffer, complexes
were immunoprecipitated under native conditions with polyclonal
antisera against cyclin D3. The presence of Tax in complexes was
assessed by Western blotting with a monoclonal antibody to Tax. (C) Tax
mutant protein in JPX9m does not compel G1-to-S progression
as measured by [3H]thymidine incorporation. JPX9 and
JPX9m cells were synchronized by serum starvation and then treated with
or without zinc for 16 h. Cells were then plated into a 96-well
plate and labeled with [3H]thymidine. Cell cycle
progression from G1 to S phase was measured by
[3H]thymidine incorporation. The relative values for JPX9
and JPX9m cells were normalized against parallel values obtained in
similarly treated Jurkat cells, with thymidine incorporation for JPX9
set at 100%. (D) Comparison of kinase activity of cyclin D3-cdk6 in
cells expressing Tax mutant or Tax wild type. In vitro kinase assays
with GST-Rb as substrate were performed. JPX9 or JPX9m cells were
synchronized by serum starvation for 20 h. Cells grown in the
presence (+; lanes 6, 8, 10, and 12) or absence ( ; lanes 5, 7, 9, and
11) of zinc for 8 h were harvested, and cell extracts were
immunoprecipitated with either anti-cdk6 (lanes 5 to 8) or anti-cyclin
D3 (lanes 9 to 10) antibody. The immunoprecipitates were tested for
kinase activity with GST-Rb as the substrate.
|
|
p19INK4d does not bind Tax.
p16INK4a
is one member of a family of INK4 inhibitors. This family has three
additional members, each capable of inhibiting the kinase activities of
cdk4 and cdk6 (9, 31, 32, 34). Previously, Tax was shown to
interact with p16INK4a (49, 80). Although the
p16INK4a gene is deleted in JPX9 cells, this does not rule
out the possibility that some of the findings described above could
occur as a consequence of Tax interaction with another members of the
INK4 family. We therefore examined this question. Because the gene for
p15INK4b is located on chromosome 9 adjacent to the
p16INK4a gene and because both are frequently deleted
together in human tumors (32, 74), we asked whether JPX9
cells might also be deleted for p15INK4b. Hence, DNAs were
prepared from several cell lines and probed by PCR with primers
specific for either the first exon or the second exon of
p15INK4b. Figure 9 shows that
neither the first exon nor the second exon of p15INK4b
could be detected in JPX9 DNA (Fig. 9, lanes 2 and 6). Control reactions showed that signals for p15INK4b were easily seen
in U2OS and MT4 DNAs (Fig. 9, lanes 1, 5, 3, and 7). An actin control
product was also clearly amplified from all DNAs (Fig. 9, lanes 9 to
11).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 9.
PCR amplification of the p15INK4b gene from
JPX9 cells. Cellular DNAs were prepared from various cell lines: U2OS
(lanes 1, 5, and 9), JPX9 (lanes 2, 6, and 10), and MT4 (lanes 3, 7, and 11). p15INK4b-specific signal was assayed by
amplification with two pairs of primers expected to produce a fragment
of 130 bp in the first exon (lanes 1 to 4) and a fragment of 231 bp in
the second exon (lanes 5 to 8) of p15INK4b, respectively. A
set of primers amplifying a fragment of 445 bp (lanes 9 to 12) in the
actin gene was used as a positive control.
|
|
We next addressed the binding properties of p19INK4d and
p18INK4c for Tax. These two proteins share 48 and 38%
protein homologies, respectively, with p16INK4a (9,
31, 34). We compared, in parallel, the affinity of Tax for
p16INK4a or p19INK4d in affinity assays (Fig.
10). The results showed that GST-p16, but not GST-p19, associated with Tax (Fig. 10). When the same
experiment was repeated with GST-p18, no detectable signal for
p18INK4c was seen in elutions from MBP-Tax resin
(59a).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 10.
Binding of p16INK4a but not
p19INK4d to Tax. Amylose-bound MBP-Tax fusion protein
(lanes 1, 2, 5, and 6) and MBP protein (lane 3, 4, 5, and 6) were
equilibrated for 3 h with 5 µl of extracts containing either
GST-p16 (lanes 1 to 4) or GST-p19 (lanes 5 to 8). The resins were
packed into columns, and flow-through fractions (ft; lanes 1, 3, 5, and
7) were collected. The resins were then extensively washed with buffer
containing 0.1 M KCl. The final wash fraction did not contain any
detectable GST-p16 or GST-p19 signal (data not shown). Beads were then
eluted with buffer containing 0.25 M KCl (lanes 2, 4, 6, and 8). The
presence of p16INK4a or p19INK4d in the
elutions was assessed by Western blotting with anti-p16 or anti-p19
antibody.
|
|
 |
DISCUSSION |
In this study we demonstrate that Tax accelerates phase
progression from G1 to S in T cells and influences the
differentiation status of muscle cells. We propose that the two
processes are linked through a common effect of Tax on G1
cyclin-cdk's, pRb, and E2F2.
Expression of Tax compels cells to exit from G1 despite an
absence of serum. This is correlated with an increase in cyclin D-cdk4
and cyclin D-cdk6 activities. We show in several settings that Tax
affects events downstream of G1 cyclin-cdk's, including hyperphosphorylation of pRb and elevation in E2F2 activity. Thus, a
compatible scenario is one in which upstream effects of Tax on cyclin
D-cdk's lead stepwise to E2F2-dependent activation of S-phase genes,
thus influencing phase progression. Without excluding a role for CKIs,
the demonstration of a physical association (Fig. 7 and 8) between Tax
and cyclins D3 and D1 provides another possible molecular mechanism
though which Tax can influence G1 cdk's. Indeed, the
association of oncoprotein with cyclins has been previously described, and this association has been invoked as one mechanism through which oncoproteins induce cell cycle dysregulation.
Thus, it has been shown that adenovirus E1A and human papillomaviruses E7 oncoproteins associate with cyclin E-p33cdk2 and/or
cyclin A-p33cdk2 (3, 21, 53, 82).
Relevant to how Tax might transform cells, there is ample evidence for
a role of G1 cyclin-cdk's in tumorigenesis. For example, there are chromosomal inversions at the cyclin D1 gene (CCDN1) in cases
of parathyroid adenoma (2, 57). In B-cell neoplasms, a
translocation of the CCDN1 gene to the immunoglobulin heavy-chain locus
has also been described (19, 84). Additionally,
amplification of CCDN1 in breast, gastric, and esophageal carcinomas
resulting in cyclin D1 overexpression has been reported (reviewed in
reference 8, 41, 48). Similarly, the gene for cyclin
D3 (CCND3) has also been found to be rearranged in several
lymphoproliferative disorders (reviewed in reference
37). Furthermore, although there are no described
mutations in cdk4 or cdk6 in human tumors, both
kinases are frequently overexpressed in several types of tumors
(81). Amplification of the gene for cdk4 is also
found in various cancers (47). Thus, if Tax indeed affects
the G1 cyclin-cdk functions, then it is reasonable that
this effect would contribute to cellular transformation.
Previously Tax was shown to bind p16INK4a (49,
80). In such a setting, Tax affects the G1-to-S
transition as a consequence of the removal of a negative influence.
However, this observation does not exclude that Tax might have a
separate and directly positive effect on the G1 cyclin
D-cdk's. Our finding that in p16INK4a-null Jurkat and JPX9
cells (80), Tax increases cyclin D-cdk4 and -cdk6 activities
is compatible with an activation route separate from the sequestration
of this particular CKI. While another INK4 family member might
intercede with Tax in JPX9 cells, the facts that p15INK4b
is also deleted and that Tax does not bind either p19INK4d
or p18INK4c make this explanation unlikely.
How then might Tax influence D cyclin-cdk's? We find that it is not
from a direct effect of Tax on the transcription of cyclin D promoters.
We have consistently failed to observe any increase in such promoter
activity as a consequence of Tax expression (59a). Indeed,
we do not find any steady-state changes in cyclin D3, cdk4, or cdk6
proteins in cells that express Tax (Fig. 6). Instead, we consider that
the effect of Tax on cyclin D-cdk activity likely occurs at a
posttranslational step since an interaction between Tax and cyclin D3
(and more weakly with cyclin D1) and a Tax-associated phosphorylation
of D3 were observed. Phosphorylation of cyclins has been described
previously for cyclins D1 and E. In both instances, the phosphorylated
form appears when the cyclins are actively complexed to cognate cdk's
(52, 79). Diehl et al. have recently suggested that
phosphorylation of cyclin D1 on threonine 286 might be an
autoregulatory mechanism that modulates degradation via the
ubiquitin-proteasome pathway (13). It is unclear to us
whether the Tax-associated cyclin D3 phosphorylation might also reflect a function or mechanism similar to that described for cyclin D1, in
addition to others. However, in our experiments we did not observe a
reduction in ambient D3 levels upon Tax expression.
Because we saw an increase in cyclin D-cdk activities in cells
expressing Tax and because we found an interaction of Tax with cyclin
D3, it is tempting to speculate on the mechanistic significance of
these observations. Direct binding by Tax could, through unknown processes, affect cyclin D3 phosphorylation, and thus changing the
phosphorylation of cyclin D3 might alter its recognition by CKIs, which
might partially explain the alterations in kinase activities.
Alternatively, phosphorylated cyclin D3 might qualitatively contribute
to making the cyclin-cdk complexes more stable and more potent. That
the interaction of Tax with cyclin D3 is physiologically relevant is
supported by the fact that a single amino acid point mutation in Tax
abolishes binding to cyclin D3 and the enhancement of cyclin
D-associated kinase activities (Fig. 8). That these Tax effects are
general is suggested by consistent findings in both T cells and
myocytes.
It is very difficult to drive serum-starved quiescent cells from
G1 into S phase. Currently, only the ectopic expression of E2F and myc (reviewed in reference 88) has shown
this capacity. Tax appears to be another oncoprotein that provides a
G1-to-S serum-independent transiting function. We suggest
that this property is a consequence of the ability of Tax to dually
inhibit p16INK4a and enhance cyclin D-cdk activities.
 |
ACKNOWLEDGMENTS |
We thank M. Benkirane, R. Chun, V. Giordano, D. Jin, I. Quinto,
E. Rich, and H. Xiao for critical readings of manuscript. We thank
C. J. Sherr for the pGEX-p19 and pGEX-p18 plasmids.
R.G. and I.S. were supported by DGF (SFB-466).
 |
ADDENDUM IN PROOF |
Recently we have demonstrated that Tax can subvert a cellular
M-phase checkpoint (D. Jin et al., Cell 93:81-91, 1998).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bldg. 4, No. 302, 900 Rockville Pike, Bethesda, MD
20892-0460. Phone: (301) 496-6680. Fax: (301) 480-3686. E-mail:
kj7e{at}nih.gov.
 |
REFERENCES |
| 1.
|
Alexandre, C.,
P. Charnay, and B. Verrier.
1991.
Transactivation of Krox-20 and Krox-24 promoters by the HTLV-1 Tax protein through common regulatory elements.
Oncogene
6:1851-1857[Medline].
|
| 2.
|
Arnold, A.,
H. G. Kim,
R. D. Gaz,
R. L. Eddy,
Y. Fukushima,
M. G. Byers,
T. B. Shows, and H. M. Kronenberg.
1989.
Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
J. Clin. Invest.
83:2034-2040.
|
| 3.
|
Arroyo, M.,
S. Bagchi, and P. Raychaudhuri.
1993.
Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
Mol. Cell. Biol.
13:6537-6546[Abstract/Free Full Text].
|
| 4.
|
Ballard, D. W.,
E. Bohnlein,
J. W. Lowenthal,
Y. Wano,
B. R. Franza, and W. C. Greene.
1988.
HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.
Science
241:1652-1655[Abstract/Free Full Text].
|
| 5.
|
Boyer, S. N.,
D. E. Wazer, and V. Band.
1996.
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
Cancer Res.
56:4620-4624[Abstract/Free Full Text].
|
| 6.
|
Brady, J.,
K. T. Jeang,
J. Duvall, and G. Khoury.
1987.
Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat.
J. Virol.
61:2175-2181[Abstract/Free Full Text].
|
| 7.
|
Brauweiler, A.,
J. E. Garrus,
J. C. Reed, and J. K. Nyborg.
1997.
Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells.
Virology
231:135-140[Medline].
|
| 8.
|
Buckley, M. F.,
K. J. Sweeney,
J. A. Hamilton,
R. L. Sini,
D. L. Manning,
R. I. Nicholson,
A. deFazio,
C. K. Watts,
E. A. Musgrove, and R. L. Sutherland.
1993.
Expression and amplification of cyclin genes in human breast cancer.
Oncogene
8:2127-2133[Medline].
|
| 9.
|
Chan, F. K.,
J. Zhang,
L. Cheng,
D. N. Shapiro, and A. Winoto.
1995.
Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
Mol. Cell. Biol.
15:2682-2688[Abstract].
|
| 10.
|
Chen, I. S.,
D. J. Slamon,
J. D. Rosenblatt,
N. P. Shah,
S. G. Quan, and W. Wachsman.
1985.
The x gene is essential for HTLV replication.
Science
229:54-58[Abstract/Free Full Text].
|
| 11.
|
DeCaprio, J. A.,
J. W. Ludlow,
J. Figge,
J. Y. Shew,
C. M. Huang,
W. H. Lee,
E. Marsilio,
E. Paucha, and D. M. Livingston.
1988.
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.
Cell
54:275-283[Medline].
|
| 12.
|
DeGregori, J.,
G. Leone,
K. Ohtani,
A. Miron, and J. R. Nevins.
1995.
E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
Genes Dev.
9:2873-2887[Abstract/Free Full Text].
|
| 13.
|
Diehl, J. A.,
F. Zindy, and C. J. Sherr.
1997.
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Genes Dev.
11:957-972[Abstract/Free Full Text].
|
| 14.
|
Dowdy, S. F.,
P. W. Hinds,
K. Louie,
S. I. Reed,
A. Arnold, and R. A. Weinberg.
1993.
Physical interaction of the retinoblastoma protein with human D cyclins.
Cell
73:499-511[Medline].
|
| 15.
|
Dyson, N.,
P. M. Howley,
K. Munger, and E. Harlow.
1989.
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
Science
243:934-937[Abstract/Free Full Text].
|
| 16.
|
Earl, P. L.,
N. Cooper, and B. Moss.
1991.
Preparation of cell culture and vaccinia virus stocks, p. 16.16.1-16.16.7.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
|
| 17.
|
Elroy-Stein, O.,
T. R. Fuerst, and B. Moss.
1989.
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
Proc. Natl. Acad. Sci. USA
86:6126-6130[Abstract/Free Full Text].
|
| 18.
|
Elroy-Stein, O., and B. Moss.
1991.
Gene expression using vaccinia/T7 RNA polymerase hybrid system, p. 16.19.1-16.19.9.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
|
| 19.
|
Erikson, J.,
J. Finan,
Y. Tsujimoto,
P. C. Nowell, and C. M. Croce.
1984.
The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus.
Proc. Natl. Acad. Sci. USA
81:4144-4148[Abstract/Free Full Text].
|
| 20.
|
Ewen, M. E.,
H. K. Sluss,
C. J. Sherr,
H. Matsushime,
J. Kato, and D. M. Livingston.
1993.
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
Cell
73:487-497[Medline].
|
| 21.
|
Faha, B.,
E. Harlow, and E. Lees.
1993.
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.
J. Virol.
67:2456-2465[Abstract/Free Full Text].
|
| 22.
|
Felber, B. K.,
H. Paskalis,
C. Kleinman-Ewing,
F. Wong-Staal, and G. N. Pavlakis.
1985.
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.
Science
229:675-679[Abstract/Free Full Text].
|
| 23.
|
Franklin, A. A., and J. K. Nyborg.
1995.
Mechanisms of Tax regulation of human T cell leukemia virus type I gene expression.
J. Biomed. Sci.
2:17-29.
[Medline] |
| 24.
|
Fujii, M.,
T. Niki,
T. Mori,
T. Matsuda,
M. Matsui,
N. Nomura, and M. Seiki.
1991.
HTLV-1 Tax induces expression of various immediate early serum responsive genes.
Oncogene
6:1023-1029[Medline].
|
| 25.
|
Fujii, M.,
P. Sassone-Corsi, and I. M. Verma.
1988.
c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.
Proc. Natl. Acad. Sci. USA
85:8526-8530[Abstract/Free Full Text].
|
| 26.
|
Gorman, C. M.,
L. F. Moffat, and B. H. Howard.
1982.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol. Cell. Biol.
2:1044-1051[Abstract/Free Full Text].
|
| 27.
|
Grana, X., and E. P. Reddy.
1995.
Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
Oncogene
11:211-219[Medline].
|
| 28.
|
Grassmann, R.,
S. Berchtold,
I. Radant,
M. Alt,
B. Fleckenstein,
J. G. Sodroski,
W. A. Haseltine, and U. Ramstedt.
1992.
Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.
J. Virol.
66:4570-4575[Abstract/Free Full Text].
|
| 29.
|
Grossman, W. J.,
J. T. Kimata,
F. H. Wong,
M. Zutter,
T. J. Ley, and L. Ratner.
1995.
Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.
Proc. Natl. Acad. Sci. USA
92:1057-1061[Abstract/Free Full Text].
|
| 30.
|
Gu, W.,
J. W. Schneider,
G. Condorelli,
S. Kaushal,
V. Mahdavi, and B. Nadal-Ginard.
1993.
Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
Cell
72:309-324[Medline].
|
| 31.
|
Guan, K. L.,
C. W. Jenkins,
Y. Li,
M. A. Nichols,
X. Wu,
C. L. O'Keefe,
A. G. Matera, and Y. Xiong.
1994.
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Genes Dev.
8:2939-2952[Abstract/Free Full Text].
|
| 32.
|
Hannon, G. J., and D. Beach.
1994.
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
Nature
371:257-261[Medline].
|
| 33.
|
Hinds, P. W., and R. A. Weinberg.
1994.
Tumor suppressor genes.
Curr. Opin. Genet. Dev.
4:135-141[Medline].
|
| 34.
|
Hirai, H.,
M. F. Roussel,
J. Y. Kato,
R. A. Ashmun, and C. J. Sherr.
1995.
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Mol. Cell. Biol.
15:2672-2681[Abstract].
|
| 35.
|
Hirama, T., and H. P. Koeffler.
1995.
Role of the cyclin-dependent kinase inhibitors in the development of cancer.
Blood
86:841-854[Free Full Text].
|
| 36.
|
Hollsberg, P., and D. A. Hafler.
1993.
Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection.
N. Engl. J. Med.
328:1173-1182[Free Full Text].
|
| 37.
|
Hunter, T., and J. Pines.
1994.
Cyclins and cancer. II: cyclin D and CDK inhibitors come of age.
Cell
79:573-582[Medline].
|
| 38.
|
Inoue, J.,
M. Seiki,
T. Taniguchi,
S. Tsuru, and M. Yoshida.
1986.
Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1.
EMBO J.
5:2883-2888[Medline].
|
| 39.
|
Jeang, K. T.,
P. R. Shank, and A. Kumar.
1988.
Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis.
Proc. Natl. Acad. Sci. USA
85:8291-8295[Abstract/Free Full Text].
|
| 40.
|
Jeang, K. T.,
S. G. Widen,
O. J. Semmes IV, and S. H. Wilson.
1990.
HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene.
Science
247:1082-1084[Abstract/Free Full Text].
|
| 41.
|
Jiang, W.,
S. M. Kahn,
N. Tomita,
Y. J. Zhang,
S. H. Lu, and I. B. Weinstein.
1992.
Amplification and expression of the human cyclin D gene in esophageal cancer.
Cancer Res.
52:2980-2983[Abstract/Free Full Text].
|
| 42.
|
Jin, D. Y.,
H. Teramoto,
C. Z. Giam,
R. F. Chun,
J. S. Gutkind, and K. T. Jeang.
1997.
A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha.
J. Biol. Chem.
272:25816-25823[Abstract/Free Full Text].
|
| 43.
|
Johnson, D. G.,
J. K. Schwarz,
W. D. Cress, and J. R. Nevins.
1993.
Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
Nature
365:349-352[Medl |